Los Angeles-based Capricor Therapeutics has been awarded nearly $3.4 million to support its Phase 1/2 HOPE-Duchenne clinical trial. The grant is from…
Articles by Margarida Azevedo, MSc
On April 9, hundreds of Texans will meet at the University of Texas Golf Club in Austin for the seventh annual…
Summit Therapeutics plc announced the publication of a study into new imaging techniques that appear to reliably and reproducibly measure utrophin protein…
PTC Therapeutics has announced it will submit the results its Phase 3 ACT DMD clinical trial for review by Health Canada…
Congenica, a global leader in the development of genome-based diagnostic technologies, has taken on a new project: to help a…
Northbrook, Illinois-based Marathon Pharmaceuticals, a biopharma that focuses on the development of medicines to treat rare diseases with no current…
Ways of better addressing the high cost of breakthrough treatments that either are or might soon be available for a range…
Tarix Orphan LLC recently announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to TXA127,…
Catabasis Pharmaceuticals and the Muscular Dystrophy Association (MDA) have announced a partnership that will support Part B of the MoveDMD…
Jiffy Lube International has raised more than $1 million dollars in a campaign to support the Muscular Dystrophy Association (MDA). The company…